Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis (CROSBI ID 322786)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Jeličić, Karlo ; Papić, Neven ; Višković, Klaudija ; Vince, Adriana Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis // American journal of tropical medicine and hygiene, 108 (2023), 3; 581-583. doi: 10.4269/ajtmh.22-0465

Podaci o odgovornosti

Jeličić, Karlo ; Papić, Neven ; Višković, Klaudija ; Vince, Adriana

engleski

Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis

Alveolar echinococcosis is an emerging zoonotic disease caused by the parasite Echinococcus multilocularis. Most patients are diagnosed at a late stage, when lifelong treatment with benzimidazoles is required to stop disease progression. However, for patients who do not tolerate benzimidazole therapy, there are no alternatives. Here, we present a patient with advanced alveolar echinococcosis who was successfully treated with amphotericin B deoxycholate and mefloquine as a rescue therapy after he developed albendazole intolerance.

Amphotericin B ; Mefloquine ; alveolar echinococcosis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

108 (3)

2023.

581-583

objavljeno

0002-9637

10.4269/ajtmh.22-0465

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost